申请人:Kartner Norbert
公开号:US20110189306A1
公开(公告)日:2011-08-04
The present invention relates to therapeutic and/or prophylactic uses of hydrazide compounds and to pharmaceutical compositions containing one or more of these compounds as an active component for treating a disease or disorder requiring modulation of vacuolar (H+)-ATPases.